1989•Medical Oncology and Tumor PharmacotherapyRequires access

Chemotherapy of Hodgkin’s lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group

Volker Diehl, Michael G. Pfreundschuh, Markus Löffler, U Rühl, Erhard Hiller, H Gerhartz, W. Wilmanns, Hartmut H. Kirchner, W. D. Schoppe, Sabine Petsch, H. Bartels, Karl-Heinz Pflüger, Johannes V. Teichmann, Roland J. Fuchs, G. Kühn, W. Oertel, Roland H. Mertelsmann, Th. Hecht, K.P. Schalk, Peter K. M. Worst, M. Wilhelmy, Winfried Gassmann, U. Loos, R. Hinterberger, H. Theml, T. Wagner, S. Samandari, W. Schäfgen, J. Preiss, Gösta Schmitz, W. Mende, B. Mödder, H. Schick

Open publisher page 20 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 20 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Dacarbazine, Procarbazine, ABVD, Vinblastine, COPP, Bleomycin, Medicine, Prednisone